Skip to main content

Table 1 Fatty acid profiles of SLOil, FOil, regular chow, and tumor tissue

From: Antitumor and anti-cachectic effects of shark liver oil and fish oil: comparison between independent or associative chronic supplementation in Walker 256 tumor-bearing rats

Fatty acids (g/100g of total fatty acids) SLOil FOil Regular chow Tumor tissue
W WSLO WFO WSLO + FO
Lauric (12:0) 1.3 ± 0.0 3.2 ± 0.3 1.1 ± 0.0 0.4 ± 0.1 0.5 ± 0.1 0.4 ± 0.1 0.4 ± 0.1
Miristic (14:0) 5.9 ± 0.1 8.7 ± 2.6 - 1.1 ± 0.4 0.7 ± 0.0 1.0 ± 0.2 1.0 ± 0.2
Palmitic (16:0) 34.2 ± 3.7 24.8 ± 2.9 22.3 ± 0.3 24.1 ± 0.9 26.1 ± 2.5 22.8 ± 1.5 26.5 ± 1.5
Palmitoleic (16:1n-7) 4.7 ± 0.4 5.5 ± 0.4 - 2.7 ± 0.1 1.4 ± 0.5 1.7 ± 0.1 1.6 ± 0.2
Stearic (18:0) 2.2 ± 0.1 2.8 ± 0.1 1.9 ± 0.0 15.7 ± 1.9 15.1 ± 0.9 8.0 ± 0.9 9.1 ± 1.4
Oleic (18:1n-9) 29.6 ± 3.1 11.8 ± 0.7 20.4 ± 0.9 24.8 ± 2.6 24.1 ± 3.0 24.8 ± 0.9 25.7 ± 0.9
Linoleic (18:2n-6) 2.1 ± 0.2 2.0 ± 0.5 50.6 ± 3.2 18.5 ± 1.3 22.9 ± 3.1 21.8 ± 2.3 22.6 ± 2.5
α-Linolenic (18:3n-3) 0.3 ± 0.0 0.8 ± 0.0 3.9 ± 0.2 0.5 ± 0.0 0.2 ± 0.0 1.0 ± 0.07 0.9 ± 0.2
Arachidonic (20:4n-6) 1.1 ± 0.1 0.9 ± 0.0 0.1 ± 0.0 16.9 ± 1.3 8.4 ± 2.1a 3.5 ± 0.8a 3.9 ± 1.4a
EPA (20:5n-3) 5.2 ± 0.5 21.3 ± 1.1 - 0.3 ± 0.1 0.6 ± 0.1 1.2 ± 0.2a 0.8 ± 0.2a
DHA (22:6n-3) 11.4 ± 1.0 17.9 ± 1.4 - 1.0 ± 0.0 2.0 ± 0.2 4.2 ± 0.7ab 4.2 ± 0.5ab
  1. Tumor tissue from Walker 256 tumor-bearing rats fed regular chow (W), supplemented with SLOil (WSLO), FOil (WFO) and both (WSLO + FO), determined by HPLC (high performance liquid chromatography). Data are presented as mean ± SEM of 3 independent measurements (HPLC) of 3 rats per group (n = 9). ap < 0.05 compared to W; bp < 0.05 compared to WSLO.